Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Researchers have now identified four regions of the genome associated with the disease, ...
Table 1 Association summary statistics across four newly associated PSC risk loci Figure 1: Odds ratios (and their 95% confidence intervals) for PSC, UC and CD across the six PSC-associated SNPs ...
Primary Sclerosing Cholangitis is an orphan disease with no FDA approved therapeutic options or viable alternatives except surgical interventions. PSC is caused by dysregulation of bile homeostasis ...
TEL AVIV, Israel, Nov. 20, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic ...
NESS ZIONA, Israel--(BUSINESS WIRE)--BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results